Quick Summary
Semawin 1.7mg Pen injection
Last updated on 26 Sep 2026 | 08:41 AM (IST)
₹3111
MRP: ₹3499
(You Save ₹388)
1 PREFILLED PEN(s) OF 3ML
Semawin 1.7mg Pen injection
Salt Composition
SEMAGLUTIDEMarketer
INTAS PHARMACEUTICALS LTD
Prepaid Only. Non-Returnable.
11% OFF
₹3111
MRP: ₹3,499.00
Inclusive of all taxes
11% Off
Salt Composition
SEMAGLUTIDEMarketer
INTAS PHARMACEUTICALS LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Hepaglide 1.7mg Injection
ALKEM LABORATOR...
₹ 568.25/injection
26% cheaper
Obesema 1.7mg Injection
ALKEM LABORATOR...
₹ 568.25/injection
26% cheaper
Noveltreat 1.7mg Injection
SUN PHARMACEUTI...
₹ 721.25/injection
7% cheaper
Sundae Pro 1.7mg Pen Injection
ERIS LIFESCIENC...
₹ 954.50/injection
23% costlier
Better Service Satisfied Customers
Introduction
Semawin 1.7mg Pen Injection contains Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It is supplied as a 6.8 mg/3 mL pre-filled pen, with each dose delivering 1.7 mg of Semaglutide. It is administered once weekly as directed by the physician.
Semaglutide is used as part of treatment for weight management in eligible adults with obesity or overweight with a weight-related health condition, along with a reduced-calorie diet and increased physical activity. The 1.7 mg dose is reached after gradual dose escalation.
Semawin 1.7mg Pen Injection is manufactured by Intas Pharmaceuticals Ltd.
Uses of Semawin 1.7mg Pen Injection
Semawin 1.7mg Pen Injection is used to:
Manage obesity in eligible adults.
Manage overweight in adults with a weight-related health condition.
Support weight loss and long-term weight maintenance.
Reduce hunger and food intake as part of a weight-management plan.
The 1.7 mg dose is used after gradual dose escalation and should be taken only according to the schedule prescribed by your doctor.
How Semawin 1.7mg Pen Injection Works
Semaglutide activates GLP-1 receptors involved in appetite and glucose regulation. It can increase insulin release when blood glucose is high and reduce glucagon release.
Semaglutide also delays gastric emptying and increases feelings of fullness. These effects can reduce hunger and food intake and support weight management.
Interaction of Semawin 1.7mg Pen Injection with Other Medicines
Insulin or sulfonylureas: May increase the risk of low blood sugar.
Other Semaglutide-containing medicines: Do not combine unless prescribed.
Other GLP-1 receptor agonists: Avoid combination unless specifically advised.
Oral medicines: Delayed gastric emptying may affect the absorption of some oral medicines.
Storage Conditions
Store in a refrigerator at 2°C to 8°C.
Do not freeze.
Do not use if frozen.
Protect from light.
Keep out of reach of children.
Follow the product instructions for storage after first use.
How to Use
Semawin 1.7mg is injected under the skin once a week.
Inject into the abdomen, thigh or upper arm.
Rotate injection sites.
It can generally be administered with or without food.
Do not inject into a vein or muscle.
Use a new needle for every injection.
Never share the pen or needles.
Do not change the dose without medical advice.
The Semawin 1.7 mg pen contains 6.8 mg/3 mL of Semaglutide.
Safety Advice
Pregnancy
Do not use Semaglutide during pregnancy. Tell your doctor if pregnancy is planned. Treatment should generally be stopped at least 2 months before planned pregnancy.
Breast Feeding
Tell your doctor if you are breastfeeding before starting treatment.
Lungs
Tell your doctor before surgery involving general anaesthesia or deep sedation because Semaglutide delays gastric emptying.
Liver
Tell your doctor if you have liver disease.
Alcohol
Alcohol may worsen nausea, vomiting and dehydration.
Driving
Low blood sugar can occur when Semaglutide is combined with insulin or sulfonylureas. Do not drive if you experience hypoglycaemia or dizziness.
Side Effects
Common side effects include:
Nausea
Vomiting
Diarrhoea
Constipation
Abdominal pain
Bloating
Indigestion
Headache
Dizziness
Decreased appetite
These effects may be more noticeable during dose escalation.
Serious Side Effects
Seek medical attention for severe persistent abdominal pain, severe allergic reactions, persistent vomiting or diarrhoea, gallbladder symptoms, significant changes in vision, or symptoms of low blood sugar.
Expert Tips
Use Semawin on the same day every week.
Do not change the dose without medical advice.
Eat smaller meals if nausea occurs.
Drink sufficient fluids.
Rotate injection sites.
Use a new needle for every injection.
Tell your doctor before surgery or deep sedation.
Seek medical attention for severe or persistent abdominal pain.
FAQs
Q1.
Why am I being given Semawin 1.7mg?
The 1.7 mg strength is used later in the Semaglutide dose-escalation schedule. It may be continued at this strength or increased further depending on how you respond and tolerate treatment.
Q2.
Do I have to increase from 1.7mg to 2.4mg?
Not necessarily. Your doctor will decide the dose that is appropriate for you. If you are having difficulty tolerating a higher dose, your treatment may need to be adjusted.
Q3.
What if I have nausea after moving to 1.7mg?
Nausea and other digestive symptoms can occur after a dose increase. Try smaller meals and maintain your fluid intake. If symptoms are severe or persistent, speak to your doctor.
Q4.
Can Semawin 1.7mg be used for long-term weight management?
Your doctor will decide how long you should continue treatment and which dose is suitable. Treatment may continue as part of a longer-term weight-management plan.
Q5.
Can I take Semawin 1.7mg with food?
Yes. Semawin is injected under the skin and can be used at any time of the day, with or without food.
Q6.
Does the 1.7mg dose work differently from the lower strengths?
The medicine is the same Semaglutide. The difference is the amount given with each weekly dose. The dose is increased gradually during treatment to improve tolerance.
Q7.
Can I use Semawin 1.7mg with another GLP-1 medicine?
No, not unless specifically prescribed. Do not combine Semawin with another Semaglutide-containing product or another GLP-1 receptor agonist.
Q8.
Can Semawin 1.7mg cause low blood sugar?
It is less likely to cause low blood sugar when used alone. The risk increases when Semaglutide is used with insulin or sulfonylureas.
Q9.
Where should I inject Semawin 1.7mg?
Inject it under the skin of your abdomen, thigh, or upper arm. Use the technique shown by your healthcare professional and rotate injection sites.
Q10.
What should I do if I miss my 1.7mg dose?
Follow the missed-dose instructions supplied with your prescription or product information. Do not take two doses together.
Q11.
Can I use Semawin 1.7mg during pregnancy?
No. Semaglutide should not be used during pregnancy. It should be stopped at least 2 months before a planned pregnancy.
Q12.
Do I need a prescription for Semawin 1.7mg?
Yes. Semawin 1.7mg is a prescription medicine and should be used under medical supervision.
Fact Box
Molecule name: | Semaglutide |
Therapeutic class: | Anti-obesity medicine |
Pharmacological class: | GLP-1 receptor agonist |
Indications: | Weight management |
References
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Naina Boruah
MSc Biomedical Science
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 26 Sep 2026 | 08:41 AM (IST)
Want to know more?
Read Our Editorial Policy